Sanofi-Aventis Downgraded by Leerink Swann to Market Perform (SNY)
Sanofi-Aventis (NYSE:SNY) was downgraded by stock analysts at Leerink Swann from an “outperform” rating to a “market perform” rating in a report issued on Friday, TheFlyOnTheWall.com reports.
Shares of Sanofi-Aventis (NYSE:SNY) opened at 50.13 on Friday. Sanofi-Aventis has a 52-week low of $42.20 and a 52-week high of $55.94. The stock’s 50-day moving average is $49.50 and its 200-day moving average is $51.90. The company has a market cap of $132.9 billion and a price-to-earnings ratio of 29.90.
A number of other analysts have also recently weighed in on SNY. Analysts at Zacks downgraded shares of Sanofi-Aventis from a “neutral” rating to an “underperform” rating in a research note to investors on Friday, September 13th. They now have a $44.00 price target on the stock. Separately, analysts at Cowen and Company downgraded shares of Sanofi-Aventis from an “outperform” rating to a “market perform” rating in a research note to investors on Wednesday, August 21st. Finally, analysts at Berenberg Bank upgraded shares of Sanofi-Aventis from a “hold” rating to a “buy” rating in a research note to investors on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to the stock. Sanofi-Aventis has a consensus rating of “Hold” and a consensus price target of $51.00.
Sanofi-Aventis is a pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.